HTA304 The Impact of Different HTA Frameworks on Time to Patient Access: A Case Study Assessing the First Commercial Launch Indications for Lynparza, Tagrisso, Imfinzi, Calquence and Enhertu
Abstract
Authors
B. Crean D. Parry A. Horsfield J. Ryan N. Oraiopoulos